Get the Stockscreener App
1.53
1.32%
0.02
After Hours:
1.56
0.03
+1.96%
Predictive Oncology Inc stock is traded at $1.53, with a volume of 167.16K.
It is up +1.32% in the last 24 hours and down -19.05% over the past month.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
See More
Previous Close:
$1.51
Open:
$1.52
24h Volume:
167.16K
Relative Volume:
0.09
Market Cap:
$10.20M
Revenue:
$1.52M
Net Income/Loss:
$-13.97M
P/E Ratio:
-0.5016
EPS:
-3.05
Net Cash Flow:
$-13.29M
1W Performance:
-1.29%
1M Performance:
-19.05%
6M Performance:
+51.49%
1Y Performance:
-46.32%
1-Day Range:
$1.50
$1.57
1-Week Range:
$1.3603
$1.61
52-Week Range:
$0.55
$3.76
Predictive Oncology Inc Stock (POAI) Company Profile
Name
Predictive Oncology Inc
Sector
Industry
Phone
412-432-1500
Address
91 43RD STREET, PITTSBURGH, MN
Compare POAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
POAI
Predictive Oncology Inc
|
1.53 | 10.20M | 1.52M | -13.97M | -13.29M | -3.05 |
|
ISRG
Intuitive Surgical Inc
|
588.50 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.65 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.18 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
330.47 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Initiated | H.C. Wainwright | Buy |
Predictive Oncology Inc Stock (POAI) Latest News
M42 and Hikma sign strategic MOU to enhance preventive and predictive cancer care in the UAE - ZAWYA
RNA Pioneer AIRNA Snags Top Biotech Executive to Lead Breakthrough Therapeutic Program - StockTitan
Predictive Oncology Inc (NASDAQ: POAI) Stock Is A Good Option To Consider - Stocks Register
(POAI)Analyzing Predictive Oncology's Short Interest - Benzinga
Stock market today: Predictive Oncology +74.80%, Blackboxstocks +70.98% among top gainers in early trading - Business Upturn
Predictive Oncology to launch ChemoFx assay in Europe - MSN
Predictive Oncology Announces Planned European Launch of - GlobeNewswire
Predictive Oncology Inc. Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay - Marketscreener.com
Predictive Oncology to launch ChemoFx drug response assay in Europe - Seeking Alpha
Predictive Oncology Expands Revolutionary Cancer Drug Testing Platform to Europe - StockTitan
Head to Head Review: Jin Medical International (NASDAQ:ZJYL) & Predictive Oncology (NASDAQ:POAI) - Defense World
Artificial Intelligence (Ai) in Drug Discovery Market Size - GlobeNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, NARI, ML, POAI on Behalf of Shareholders - GlobeNewswire Inc.
Jin Medical International (NASDAQ:ZJYL) versus Predictive Oncology (NASDAQ:POAI) Critical Comparison - Defense World
Contrasting Predictive Oncology (NASDAQ:POAI) & Jin Medical International (NASDAQ:ZJYL) - Defense World
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ACCD, SHOT, POAI, FUBO on Behalf of Shareholders - The Malaysian Reserve
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Me - GuruFocus.com
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates RHE, FUBO, POAI on Behalf of Shareholders - GlobeNewswire
Renovaro Biosciences Merges with Predictive Oncology - MSN
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Predictive Oncology Inc.POAI - The Malaysian Reserve
PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc.POAI - Business Wire
Predictive Oncology shareholders elect directors, ratify auditor By Investing.com - Investing.com Australia
Renovaro Issues Shareholder Letter and Provides Corporate Update - The Manila Times
Straub Metal acquired by Norfolk Iron & Metal - Pennsylvania Business Report
Renovaro To Buy Predictive Oncology In All-Stock Deal - Pulse 2.0
Predictive Oncology shares rise 71% as takeover by Renovaro is announced - Mugglehead
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SSY, FUBO, RHE, POAI on Behalf of Shareholders - The Malaysian Reserve
Renovaro Set to Acquire Predictive Oncology - MD+DI
Renovaro to Acquire Predictive Oncology - citybiz
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Predictive Oncology Inc. (NasdaqPOAI), SunLink Health Systems, Inc. (NYSE AmericanSSY), Universal Stainless & Alloy Products, Inc. (NasdaqUSAP), Patterson Companies, Inc. (Nasdaq - GlobeNewswire Inc.
Stock market news: fuboTV +239.58%, Predictive Oncology +87.08% among top gainers during mid day trading - Business Upturn
Stock market news: Boxlight increased by 284.78% while AEON Biopharma declined by 66.75% during mid day trading - Business Upturn
M&A: Predictive Oncology to be Acquired by Renovaro - HIT Consultant
POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the - WICZ
POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders - Business Wire
Renovaro to acquire Predictive Oncology in all-stock transaction - TipRanks
Renovaro to Acquire Predictive Oncology in All-Stock Transaction - The Manila Times
Predictive Oncology in Deal to Be Sold to Renovaro - MarketWatch
Predictive Oncology Announces Agreement to be Acquired by Renovaro - GlobeNewswire
Predictive Oncology to Be Acquired by Renovaro in AI-Driven Cancer Research Merger - StockTitan
Renovaro Inc. entered into a binding letter of intent to acquire Predictive Oncology Inc. for for $6.2 million. - Marketscreener.com
OSUR Stock Surges Over 5% Amid Market Activity - GuruFocus.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROIC, CTV, SASR on Behalf of Shareholders - PrimePublishers.com
Intelligent Bio Solutions (NASDAQ:INBS) Stock Quotes, Forecast and News Summary - Benzinga
Artificial Intelligence in Oncology Market to Hit US$ 11.52 Billion by 2030 with 29.4% CAGR | MarketsandMarkets - The Malaysian Reserve
Artificial Intelligence in Oncology Market to Hit US$ 11.52 Billion by 2030 with 29.4% CAGR | MarketsandMarkets™ - PR Newswire UK
BullFrog AI Announces Appointment of Chief Financial Officer - The Manila Times
AI in Precision Medicine Market to Hit US$ 3.92 Billion by 2030 with 30.7% CAGR | MarketsandMarkets™. - GlobeNewswire
Addressing the oncological ‘other’: How predictive analysis can shift the research imbalance - pharmaphorum
Head to Head Contrast: Predictive Oncology (NASDAQ:POAI) vs. Avitar (OTCMKTS:AVTI) - Defense World
Certis Oncology Solutions Unveils CertisOI Assistant™ - Business Wire
Predictive Oncology Inc Stock (POAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
10.10%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):